Repositioning of the antipsychotic drug TFP for sepsis treatment

[1]  K. Asehnoune,et al.  Contribution of Dendritic Cell Responses to Sepsis-Induced Immunosuppression and to Susceptibility to Secondary Pneumonia , 2018, Front. Immunol..

[2]  Q. Lei,et al.  The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosis , 2018, Cell Death & Disease.

[3]  Vijay Kumar,et al.  Dendritic cells in sepsis: Potential immunoregulatory cells with therapeutic potential , 2018, Molecular immunology.

[4]  W. Cheadle,et al.  Pathogen- and Danger-Associated Molecular Patterns and the Cytokine Response in Sepsis. , 2018, Surgical infections.

[5]  Yury B. Porozov,et al.  TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis , 2017, Vaccines.

[6]  Dong-Dong Wu,et al.  Dendritic Cells in Sepsis: Pathological Alterations and Therapeutic Implications , 2017, Journal of immunology research.

[7]  R. Bjerkvig,et al.  Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination , 2017, Journal of experimental & clinical cancer research : CR.

[8]  Chien-Chang Lee,et al.  Preadmission Use of Calcium Channel Blocking Agents Is Associated With Improved Outcomes in Patients With Sepsis: A Population-Based Propensity Score–Matched Cohort Study , 2017, Critical care medicine.

[9]  J. Dagvadorj,et al.  Lipopolysaccharide Induces Alveolar Macrophage Necrosis via CD14 and the P2X7 Receptor Leading to Interleukin-1α Release. , 2015, Immunity.

[10]  M. Fink,et al.  Strategies to improve drug development for sepsis , 2014, Nature Reviews Drug Discovery.

[11]  C. Adams,et al.  Trifluoperazine versus placebo for schizophrenia. , 2014, The Cochrane database of systematic reviews.

[12]  M. Nagarkatti,et al.  Role of cytokines as a double-edged sword in sepsis. , 2013, In vivo.

[13]  Hong Soon Yim,et al.  Effect of 1‐methyl‐D‐tryptophan and adoptive transfer of dendritic cells on polymicrobial sepsis induced by cecal content injection , 2013, Microbiology and immunology.

[14]  T. van der Poll,et al.  Severe sepsis and septic shock. , 2013, The New England journal of medicine.

[15]  Janet S. Lee,et al.  Calcium/calmodulin‐dependent protein kinase (CaMK) Iα mediates the macrophage inflammatory response to sepsis , 2011, Journal of leukocyte biology.

[16]  Jon Cohen,et al.  A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis* , 2010, Critical care medicine.

[17]  H. Kwon,et al.  A Novel Ca2+/Calmodulin Antagonist HBC Inhibits Angiogenesis and Down-regulates Hypoxia-inducible Factor* , 2010, The Journal of Biological Chemistry.

[18]  E. Toone,et al.  Identification and inhibitory properties of a novel Ca(2+)/calmodulin antagonist. , 2010, Biochemistry.

[19]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[20]  Hayyoung Lee,et al.  The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex , 2009, Nature.

[21]  Pierre Asfar,et al.  Activated protein C improves lipopolysaccharide-induced cardiovascular dysfunction by decreasing tissular inflammation and oxidative stress* , 2009, Critical care medicine.

[22]  F. Lang,et al.  Ion Channels Modulating Mouse Dendritic Cell Functions1 , 2008, The Journal of Immunology.

[23]  Yan Li,et al.  Essential roles of TGF‐β in anti‐CD3 antibody therapy: reversal of diabetes in nonobese diabetic mice independent of Foxp3+CD4+ regulatory T cells , 2008, Journal of leukocyte biology.

[24]  J. Marshall,et al.  NEUTRALIZATION OF TUMOR NECROSIS FACTOR IN PRECLINICAL MODELS OF SEPSIS , 2005, Shock.

[25]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[26]  B. Soares,et al.  Trifluoperazine for schizophrenia. , 2004, The Cochrane database of systematic reviews.

[27]  L. Moldawer,et al.  Sepsis and the Dendritic Cell , 2003, Shock.

[28]  Jonathan Cohen.  The immunopathogenesis of sepsis , 2002, Nature.

[29]  T. van der Poll,et al.  RECOMBINANT HUMAN ACTIVATED PROTEIN C (XIGRIS®) , 2002, International journal of clinical practice.

[30]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[31]  Wan-Wan Lin,et al.  Involvement of protein kinases in the potentiation of lipopolysaccharide‐induced inflammatory mediator formation by thapsigargin in peritoneal macrophages , 2001, Journal of leukocyte biology.

[32]  A. Means,et al.  Calmodulin: a prototypical calcium sensor. , 2000, Trends in cell biology.

[33]  J. Vincent,et al.  Has the mortality of septic shock changed with time. , 1998, Critical care medicine.

[34]  L. Delbaere,et al.  Trifluoperazine-induced conformational change in Ca2+-calmodulin , 1994, Nature Structural Biology.

[35]  M. Asano.  Divergent pharmacological effects of three calmodulin antagonists, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), chlorpromazine and calmidazolium, on isometric tension development and myosin light chain phosphorylation in intact bovine tracheal smooth muscle. , 1989, The Journal of pharmacology and experimental therapeutics.

[36]  H. Hidaka,et al.  Effect of calmodulin inhibitors on thyroid hormone secretion. , 1986, Endocrinology.

[37]  H. Hidaka,et al.  N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[38]  B. Dotson.  Calcium Channel Blockers and Sepsis Outcomes. , 2018, Critical care medicine.

[39]  Monika Wieliczko,et al.  [Calcium homeostasis]. , 2013, Wiadomosci lekarskie.

[40]  M. Rossol,et al.  LPS-induced cytokine production in human monocytes and macrophages. , 2011, Critical reviews in immunology.

[41]  R. Maier,et al.  Calcium and calmodulin regulate lipopolysaccharide-induced alveolar macrophage production of tumor necrosis factor and procoagulant activity. , 1996, Archives of surgery.